Ryan & Maniskas, LLP Announces Investigation of Symmetricom Inc.
WAYNE, Pa., Oct. 24, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Symmetricom Inc. ("Symmetricom" or the "Company") (NASDAQ: SYMM) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Microsemi Corporation in a deal valued at approximately $230 million.
If you own shares of Symmetricom and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/symm. You may also email Mr. Maniskas at firstname.lastname@example.org.
Under the terms of the proposed transaction, Symmetricom's stockholders will receive $7.18 for each share of Symmetricom common stock they own.
Our investigation concerns possible breaches of fiduciary duty and other violations of state law by Symmetricom's Board of Directors for not acting in the Company's shareholders' best interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. To learn more about the class action process, please visit: www.rmclasslaw.com.
SOURCE Ryan & Maniskas, LLP
More by this Source
Ryan & Maniskas, LLP Announces Investigation of OSI Systems, Inc.
Dec 10, 2013, 11:39 ET
Ryan & Maniskas, LLP Announces Investigation of Barnes & Noble, Inc.
Dec 09, 2013, 15:51 ET
Ryan & Maniskas, LLP Files Class Action Lawsuit Against PhotoMedex, Inc.
Dec 06, 2013, 18:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.